All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

PULLULAN-DOX/PVA-PDMS BIOPOLYMERIC CORE-SHELL NANOFIBERS POTENTIAL FOR DRUG DELIVERY SYSTEMS

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F46747885%3A24410%2F24%3A00012526" target="_blank" >RIV/46747885:24410/24:00012526 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.7216/teksmuh.1496634" target="_blank" >https://doi.org/10.7216/teksmuh.1496634</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.7216/teksmuh.1496634" target="_blank" >10.7216/teksmuh.1496634</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    PULLULAN-DOX/PVA-PDMS BIOPOLYMERIC CORE-SHELL NANOFIBERS POTENTIAL FOR DRUG DELIVERY SYSTEMS

  • Original language description

    In this research, a novel drug delivery system shell was created by loading doxorubicin hydrochloride (DOX) into Pullulan and integrating the core into a polyvinyl alcohol (PVA) and Polydimethoxysilane (PDMS) composite matrix. The incorporation of DOX into the pullulan solution was carried out to take advantage of Pullulan‘s biocompatibility, biodegradability and hydrophilic nature. The hydrophilic nature of PVA can result in rapid drug release, while the hydrophobic nature of PDMS allows for slower drug release. The use of PVA-PDMS polymers together in the shell offers an initial rapid release followed by a prolonged and controlled drug release. This combination is superior to PVA or PDMS in terms of safety, mechanical strength, flexibility, controlled drug release and structural stability. This innovative composite system was designed to optimise DOX‘s controlled release to increase its therapeutic efficacy and reduce systemic toxicity. The kinetics of the drug release was characterised by an initial burst release followed by a sustained release phase, allowing controlled and prolonged release of the chemotherapeutic agent. Our results indicate that the pullulan/PVA-PDMS composite is a promising candidate for practical drug delivery applications, especially in cancer therapy.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

  • OECD FORD branch

    20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Tekstil ve Muhendis

  • ISSN

    1300-7599

  • e-ISSN

  • Volume of the periodical

    31

  • Issue of the periodical within the volume

    135

  • Country of publishing house

    TR - TURKEY

  • Number of pages

    12

  • Pages from-to

    110-120

  • UT code for WoS article

  • EID of the result in the Scopus database

    2-s2.0-85207036820